Skip to content
Disclosery

Prostatis Group LLC: CME position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Prostatis Group LLC on CME, newest first. How the timeline and the estimate are built.

Prostatis Group LLC held 0 CME shares at 2025-09-30 per its 13F-HR filed 2025-11-04.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -745 shares

    13F-HR 0001214659-25-015832 filed by Prostatis Group LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 745 shares
    Change vs previous 13F -378 shares

    0.06% of the 13F portfolio, value $205,337.

    13F-HR 0001214659-25-010914 filed by Prostatis Group LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 1,123 shares
    Change vs previous 13F -346 shares

    0.09% of the 13F portfolio, value $297,921.

    13F-HR 0001214659-25-007987 filed by Prostatis Group LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 1,469 shares
    Change vs previous 13F not available

    0.1% of the 13F portfolio, value $341,146.

    13F-HR 0001214659-25-004616 filed by Prostatis Group LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).